Nano-X Imaging (NASDAQ:NNOX) CEO Acquires $11,250.00 in Stock

Posted by Brian Himes on Oct 20th, 2026

Nano-X Imaging Ltd. (NASDAQ:NNOX – Get Free Report) CEO Erez Meltzer bought 25,000 shares of the stock in a transaction that occurred on Monday, October 19th. The stock was bought at an average cost of $0.45 per share, for a total transaction of $11,250.00. Following the transaction, the chief executive officer owned 90,443 shares of the company’s stock, valued at $40,699.35. The trade was a 38.20% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Erez Meltzer also recently made the following trade(s):

On Tuesday, September 15th, Erez Meltzer bought 10,000 shares of Nano-X Imaging stock. The shares were bought at an average price of $0.69 per share, for a total transaction of $6,900.00.
On Thursday, September 10th, Erez Meltzer purchased 10,000 shares of Nano-X Imaging stock. The shares were bought at an average cost of $0.78 per share, with a total value of $7,800.00.
On Monday, August 10th, Erez Meltzer purchased 9,443 shares of Nano-X Imaging stock. The shares were bought at an average cost of $1.03 per share, with a total value of $9,726.29.
On Monday, July 27th, Erez Meltzer purchased 36,000 shares of Nano-X Imaging stock. The stock was bought at an average price of $0.93 per share, with a total value of $33,480.00.

Nano-X Imaging Stock Down 9.5%

NASDAQ:NNOX opened at $0.41 on Tuesday. Nano-X Imaging Ltd. has a twelve month low of $0.36 and a twelve month high of $4.71. The firm has a market capitalization of $32.22 million, a price-to-earnings ratio of -0.19 and a beta of 1.28. The stock’s 50 day moving average price is $0.74 and its two-hundred day moving average price is $1.32.

Nano-X Imaging (NASDAQ:NNOX – Get Free Report) last released its quarterly earnings data on Wednesday, September 9th. The company reported ($0.79) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.63). The company had revenue of $4.16 million during the quarter, compared to analyst estimates of $5.38 million. Nano-X Imaging had a negative net margin of 926.05% and a negative return on equity of 116.93%. As a group, analysts anticipate that Nano-X Imaging Ltd. will post -1.23 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of NNOX. Engineers Gate Manager LP bought a new position in Nano-X Imaging in the 2nd quarter valued at about $42,000. Squarepoint Ops LLC bought a new stake in shares of Nano-X Imaging during the second quarter worth approximately $66,000. PCM Encore LLC bought a new stake in shares of Nano-X Imaging during the second quarter worth approximately $53,000. Bank of America Corp DE grew its position in shares of Nano-X Imaging by 711.1% in the first quarter. Bank of America Corp DE now owns 484,328 shares of the company’s stock valued at $1,099,000 after purchasing an additional 424,618 shares during the last quarter. Finally, Royal Bank of Canada grew its position in shares of Nano-X Imaging by 27.8% in the first quarter. Royal Bank of Canada now owns 194,166 shares of the company’s stock valued at $440,000 after purchasing an additional 42,273 shares during the last quarter. Institutional investors and hedge funds own 21.49% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on NNOX. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $5.00 price target on shares of Nano-X Imaging in a research report on Monday, August 17th. Zacks Research upgraded shares of Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Alliance Global Partners downgraded shares of Nano-X Imaging from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $5.00 to $3.00 in a research report on Tuesday, July 7th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Nano-X Imaging in a research report on Friday, October 2nd. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Nano-X Imaging presently has an average rating of “Moderate Buy” and a consensus target price of $4.33.

Get Our Latest Report on Nano-X Imaging

Nano-X Imaging Company Profile

(Get Free Report)

Nano-X Imaging Ltd. is a medical technology company developing digital X-ray and medical imaging solutions. Its primary product is the Nanox.ARC, a digitally driven X-ray system designed to provide imaging capabilities in hospitals, clinics and other healthcare settings. The company’s approach is intended to support more accessible and affordable diagnostic imaging, including in locations where conventional radiology infrastructure may be limited.

Nano-X also offers cloud-based services through its Nanox.CLOUD platform, which is designed to connect imaging devices, manage examinations and facilitate the transmission and review of medical images.